Premium
Ulcer‐healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage
Author(s) -
Lai K. C.,
Hui W. M.,
Wong B. C. Y.,
Hu W. H. C.,
Lam S. K.
Publication year - 2000
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1046/j.1365-2036.2000.00803.x
Subject(s) - medicine , omeprazole , helicobacter pylori , gastroenterology , clarithromycin , peptic , endoscopy , duodenal ulcer , peptic ulcer , surgery
Aim: To study the efficacy of a 2‐week anti‐ Helicobacter therapy in the healing of H. pylori ‐associated bleeding peptic ulcers. Methods: Omeprazole 20 mg, clarithromycin 500 mg and amoxycillin 1 g, twice daily, were given for 2 weeks to 180 patients with H. pylori ‐associated bleeding peptic ulcers. Endoscopy was repeated 4 weeks after the eradication therapy to assess healing of the peptic ulcers. Results: Repeat endoscopies were performed in 168 patients (42 gastric ulcer and 126 duodenal ulcer) who followed the protocol. Thirty‐eight patients with bleeding gastric ulcers and 124 patients with bleeding duodenal ulcers healed 4 weeks after treatment (per protocol analysis; gastric ulcer: 91% vs. duodenal ulcer: 98%; P =0.035). No patients who were compliant to the study medications suffered from re‐bleeding. Stepwise discriminant analysis demonstrated that small ulcers (< 15 mm) and the presence of duodenal ulcers best predicted healing of the peptic ulcers. Conclusions: Ulcer‐healing drugs should be continued after a 2‐week course of omeprazole‐containing anti‐ Helicobacter therapy for gastric ulcers and large peptic ulcers that have bled, but can be omitted in most patients with a bleeding duodenal ulcer.